EGFR and neoplasm: In the ‘Drug Resistance: Anti-tumor Drugs’ module, it was found that C1 were associated with ‘EGFR tyrosine kinase inhibitor resistance’, which aligns with their intrinsic or early resistance to targeted EGFR inhibition.